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Compounds of natural origin and their derivatives play an
increasingly important role in medicine and pharmacology.
Approximately 60% of therapeutic drugs used in the
treatment of cancer are compositions comprising natural
compounds and/or their derivatives.
C. G. Vazhappilly and H. P. Vasantha Rupasinghe
demonstrated that an apple flavonoid fraction (AF4) can
protect oxidative DNA damage in vitro and facilitate repair
mechanisms in normal human bronchial epithelial cells
exposed to carcinogen-induced DNA damage as nicotine-
derived nitrosamine ketones, nitrosamine ketones-acetate,
methotrexate, and cisplatin. When DNA damage and
repair mechanisms were evaluated, it was found that AF4
pretreated cells showed lower cytotoxicity, total ROS gen-
eration, and DNA fragmentation along with consequent
inhibition of DNA tail moment after phosphorylation of
histone (γ-H2AX).
A. Ortiz-Espín et al. evaluated an extract of an Antarctic
plant Deschampsia antarctica (EDA) in young human
fibroblasts exposed to H2O2 to survive in extreme conditions.
They measured cell proliferation, viability, and senescence-
associated β-galactosidase (SA-β-Gal). They found that
EDA per se promoted cell proliferation and viability and
increased the expression of antisenescence-related markers.
They also tested the expression of several senescence-
associated proteins including redox protein thioredoxin,
sirtuin 1, and lamin A/C and the replicative protein PCNA.
Then, they induced senescence in human fibroblasts and they
found that an EDA treatment significantly inhibited the
increase in SA-β-Gal levels induced by H2O2 and promoted
the expression of sirtuin 1 and lamin A/C proteins. The
results suggest that EDA protects human fibroblasts from
cellular senescence, pointing to this compound as a potential
therapeutic agent to treat or prevent skin senescence.
G. Carrasco-Torres et al. used quercetin, a flavonoid
considered as chemopreventive agent in different types of
cancer. They demonstrated that quercetin was able to pre-
vent and reverse rat liver preneoplastic lesions when using
the modified resistant hepatocyte model by downregulating
the expression of EGFR and phosphorylating the status
of Src-1, STAT5, and Sp-1. Then, they concluded that
quercetin reversed preneoplastic lesions and had a chemo-
preventive effect on the liver of rats. Plant-based com-
pounds are still researched for their anticancer activity
and for their quantity in plants. Therefore, the modern
chromatographic methods are applied to quantify them
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in plants, as the ultraperformance liquid chromatography-
tandem mass spectrometry.
T. Kubrak et al. studied the effect of 20 coumarin deriva-
tives on the cytotoxicity and expression of encoding proteins
responsible for multidrug resistance (MDR) and genes
involved in such resistance in cancer cells. Such genes are
considered as the major cause of failure of cancer chemother-
apy, demonstrated as overexpression of membrane trans-
porters primarily from the ABC family which actively
remove cytostatics from the tumor cell. They studied pro-
teins as MDR1, MRP, and LRP and genes as BCRP in the
presence and absence of mitoxantrone in 5 cell lines derived
from the human hematopoietic system and found that
leukemia cells exhibited a multidrug resistance phenotype.
M. Mehdi et al. evaluated glutamate and glucose metabo-
lism through GDH and LDH enzyme activity, oxidant, and
antioxidative status among breast cancer patients from Addis
Ababa, Ethiopia. Catalytic activities of glutamate dehydroge-
nase, lactate dehydrogenase, and oxidative stress index were
significantly increased both in serum and cancerous tissues
of breast cancer patients as compared to control groups of
breast cancer patients. They concluded that catalytic activi-
ties of GDH and LDH among breast cancer patients were
significantly higher than control groups and noncancerous
tissues of breast cancer patient. A problem of cancer che-
motherapy is the high cytotoxicity toward normal rapidly
proliferating cells, especially the bone marrow. In order
to mitigate side effects, modified therapeutic regimens such
as combination therapy have been introduced.
A. Och et al. studied the content of alkaloids as sangui-
narine, berberine, protopine, and chelidonine, unidentified
in plant species known for their anticancer activity. Plant-
based compounds are still researched for their anticancer
activity and for their quantity in plants. Therefore, the
modern chromatographic methods are applied to quantify
them in plants, for example, UPLC-MS/MS (ultraperfor-
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